Aniridia North America (ANA) announces its biennial scientific event to strengthen and expand research focused on aniridia and related problems. The 2025 Aniridia North America Symposium: PAX6, Aniridia, and Beyond will bring together top researchers from around the world for the presentation and discussion of innovative and often unpublished research at the forefront of understanding …
Guest: John Freeman, MD Dr. Freeman is Board Certified by the American Board of Ophthalmology and specializes in cataract surgery and corneal disease. Prior to receiving his medical degree, Dr. Freeman received his B.A. in English from Davidson College in North Carolina. Dr. Freeman earned his Medical Degree from the University of Tennessee College of …
ANA desires to increase collaboration internationally and serve as a collective voice of North American stakeholders to the international aniridia community. In pursuit of that vision, representatives from ANA were honored to be invited to and to participate in the 7th European Aniridia Conference, hosted by Aniridia Sweden, together with Linkoping University and Aniridia Europe. The …
Read how scientists are working to solve the aniridia puzzle. A patient-focused summary of presentations given at the 2023 ANA Symposium can be downloaded here.
Thank you to all who supported and donated to ANA in 2023. Thanks to your support, great things were achieved! The ANA Board of Directors is looking forward to another great year in 2024.
The infographics below provide a snapshot of the accomplishments in 2023 and highlight some goals set for 2024.
Charlottesville, VA – Aniridia North America (ANA) announces its biennial scientific event to strengthen and expand research focused on aniridia and related problems. The 2023 Aniridia North America Symposium: PAX6, Aniridia, and Beyond will bring together top researchers from around the world for the presentation and discussion of innovative and often unpublished research at the …
ANA is pleased to announce that the article “Report on the 2021 Aniridia North America symposium on PAX6, aniridia, and beyond” has been published in July 2023 issue of The Ocular Surface journal. Abstract “The inaugural Aniridia North America (ANA) Symposium was held on the first weekend in November 2021 in Charlottesville, VA, at the University of Virginia. …
ANA is pleased to announce the creation of a Patient and Family Advisory Board. The purpose of the ANA Patient and Family Advisory Board (PFAB) is to provide persons with aniridia and their family members a pathway to actively engage with ANA, identify opportunities for patient community engagement, and provide feedback from a patient perspective regarding …
ANA recognizes that, in the rare disease community, we are stronger when working together with those who share common goals. Recently, ANA acted upon this vision by joining Global Genes and formalizing partnerships with VFT and the IWSA.
Focal Point is a webinar series presented by Aniridia North America. This is the second episode, with a focus of Glaucoma in Aniridia. Dr. Peter Netland joins Janelle Collins to give an overview of Glaucoma and to answer a multitude of frequently asked questions that were not covered in episode 1.
Aniridia North America
106 W. Calendar Ave
Suite 122
LaGrange, IL 60525
Aniridia North America is registered as a 501(c)(3) non-profit organization in the United States.
EIN: 86-2917141
